Journey Medical Corp Announces New Journey with the Experts Video Featuring Danilo C. Del Campo, MD

Dr. Del Campo discusses psoriasis, an immune-mediated disease that affects more than 8 million people in the United States
SCOTTSDALE, Ariz. - Oct. 16, 2020 - PRLog -- Journey Medical Corporation (Journey Medical) today released a new Journey with the Experts video featuring Danilo C. Del Campo, MD (Dr. Danny), a board-certified dermatologist with Chicago Skin Clinic. Dr. Danny discusses psoriasis with Journey Medical, including what it is, why it occurs and how those affected can seek treatment from their local dermatology practice.

According to the National Psoriasis Foundation and current studies, more than 8 million people in the United States have psoriasis. Psoriasis can develop at any age, but often appears between the ages of 15 and 25. To view the Journey with the Experts video featuring Dr. Danny, please visit

About Journey with the Experts

Journey with the Experts is an educational initiative supported by Journey Medical Corporation, the medical dermatology company. The initiative is designed to educate the general public on common medical dermatology skin disorders and explain how these conditions can be treated at local dermatology practices.

The information, including, without limitation, topics, presentations, discussions, content, descriptions or any other material contained herein is for informational purposes only. None of the material herein is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified HCP with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking it because of something you have heard, observed, or inferred herein. Any reliance is strictly prohibited.

About Journey Medical Corporation

Journey Medical is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The company currently markets five products that help treat and heal common skin conditions. The Journey Medical team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona and is a partner company of Fortress Biotech, Inc. (NASDAQ:FBIO). For additional information about Journey Medical, visit

About Danilo C. Del Campo, MD

Danilo C. Del Campo, MD (Dr. Danny), is a board-certified dermatologist and a Chicago local. He completed his undergraduate studies at the University of Chicago with double honors in both Biology and Music (piano performance). Dr. Danny then received his medical degree (MD) from Rush Medical College. During his studies, he was inducted into the prestigious Gold Humanism Society for his charitable work in the community. Dr. Danny completed his internship in Internal Medicine at University of Illinois at Chicago and then pursued residency in Dermatology at New York Medical College in New York City. During his training, he was selected as Chief Resident for his program and was three-times awarded the Cynthia Saporito Award for his excellence in teaching. He has participated in many clinical research studies and has authored numerous publications in peer reviewed dermatology journals. For more information about Dr. Danny, please visit

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. As used below and throughout this press release, the words "we", "us" and "our" may refer to Fortress individually, a partner company individually, or Fortress together with one or more partner companies, as dictated by context. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of research and development activities; uncertainties relating to preclinical and clinical testing; risks relating to the timing of starting and completing clinical trials; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as may be required by law.

Jaclyn Jaffe and William Begien
Fortress Biotech, Inc.
(781) 652-4500
Source: » Follow
Email:*** Email Verified
Location:Scottsdale - Arizona - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Sep 22, 2021
Journey Medical Corporation PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share